{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:36:50Z","timestamp":1771857410052,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.canlet.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T19:20:16Z","timestamp":1310844016000},"page":"11-19","source":"Crossref","is-referenced-by-count":37,"title":["Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells"],"prefix":"10.1016","volume":"311","author":[{"given":"Tzu-Chao","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Syun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuohui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Shiun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chih","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinchi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.06.007_b0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ctrv.2006.01.001","article-title":"Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer","volume":"32","author":"Serrano-Olvera","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2011.06.007_b0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2011.06.007_b0015","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-04-4559","article-title":"ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin\/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells","volume":"66","author":"Klos","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2011.06.007_b0025","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.06.007_b0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.bjc.6603581","article-title":"In ovarian cancer the prognostic influence of HER2\/neu is not dependent on the CXCR4\/SDF-1 signalling pathway","volume":"96","author":"Pils","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.06.007_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.1066","article-title":"Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells","volume":"32","author":"Lin","year":"2001","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2011.06.007_b0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ptr.1264","article-title":"Inhibitory effect of magnolol on tumour metastasis in mice","volume":"17","author":"Ikeda","year":"2003","journal-title":"Phytother. Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0705024","article-title":"Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells","volume":"138","author":"Yang","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mc.20274","article-title":"Involvement of Ras\/Raf-1\/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells","volume":"46","author":"Hsu","year":"2007","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2011.06.007_b0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcb.21100","article-title":"Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells","volume":"101","author":"Huang","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2011.06.007_b0060","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bcp.2008.03.022","article-title":"Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2\/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells","volume":"75","author":"Lee","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0065","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1021\/jf901477g","article-title":"Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21\/Cip1","volume":"57","author":"Chen","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.canlet.2011.06.007_b0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF00168746","article-title":"Anti-inflammatory and analgesic effects of magnolol","volume":"346","author":"Wang","year":"1992","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2004.05.047","article-title":"In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp","volume":"496","author":"Park","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0080","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.molimm.2006.12.004","article-title":"Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation","volume":"44","author":"Tse","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2011.06.007_b0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02976465","article-title":"Antifungal activity of magnolol and honokiol","volume":"23","author":"Bang","year":"2000","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ptr.736","article-title":"Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis","volume":"15","author":"Ho","year":"2001","journal-title":"Phytother. Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.biocel.2004.05.021","article-title":"Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid","volume":"37","author":"Fong","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2011.06.007_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-2999(03)02075-2","article-title":"Honokiol and magnolol induce Ca2+ mobilization in rat cortical neurons and human neuroblastoma SH-SY5Y cells","volume":"474","author":"Zhai","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2009.02.032","article-title":"Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: in vitro and in vivo","volume":"281","author":"Hsu","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2011.06.007_b0110","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1016\/j.febslet.2007.08.021","article-title":"Human manganese superoxide dismutase suppresses HER2\/neu-mediated breast cancer malignancy","volume":"581","author":"Chuang","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2011.06.007_b0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/carcin\/bgm263","article-title":"Downregulation of HER2 by RIG1 involves the PI3K\/Akt pathway in ovarian cancer cells","volume":"29","author":"Ou","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2011.06.007_b0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejphar.2007.01.095","article-title":"Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB","volume":"565","author":"Tanaka","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2011.06.007_b0125","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1541-7786.MCR-06-0076","article-title":"Honokiol potentiates apoptosis. Suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway","volume":"4","author":"Ahn","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/08977190500361812","article-title":"Cyclins: roles in mitogenic signaling and oncogenic transformation","volume":"24","author":"Musgrove","year":"2006","journal-title":"Growth Factors"},{"key":"10.1016\/j.canlet.2011.06.007_b0135","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1158\/1078-0432.CCR-04-1061","article-title":"Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2 and prognosis","volume":"10","author":"Pellikainen","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.21769","article-title":"MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2","volume":"119","author":"Ke","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.06.007_b0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cellsig.2008.02.017","article-title":"HER2-dependent MMP-7 expression is mediated by activated STAT3","volume":"20","author":"Yuan","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.canlet.2011.06.007_b0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbrc.2008.09.135","article-title":"Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells","volume":"377","author":"Park","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2011.06.007_b0155","first-page":"1375","article-title":"TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells","volume":"25","author":"Kim","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2011.06.007_b0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.canlet.2008.10.013","article-title":"Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9","volume":"275","author":"Kim","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2011.06.007_b0165","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1038\/sj.onc.1207485","article-title":"Upregulation of IKKalpha\/IKKbeta by integrin-linked kinase is required for HER2\/neu-induced NF-kappaB antiapoptotic pathway","volume":"23","author":"Makino","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.06.007_b0170","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis","volume":"21","author":"Gottlieb","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.06.007_b0175","first-page":"1855","article-title":"Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association","volume":"61","author":"Ellerbroek","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ijc.20228","article-title":"Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells","volume":"111","author":"O-charoenrat","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.06.007_b0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10585-004-3503-x","article-title":"Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice","volume":"21","author":"Suarez-Cuervo","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2011.06.007_b0190","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-04-2807","article-title":"Genistein inhibits p38 Map kinase activation, matrix metalloproteinase type 2 and cell invasion in human prostate epithelial cells","volume":"65","author":"Huang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0195","doi-asserted-by":"crossref","first-page":"14675","DOI":"10.1074\/jbc.M411625200","article-title":"H-Ras-specific activation of Rac-MKK3\/6\u2013p38 pathway: its critical role in invasion and migration of breast epithelial cells","volume":"280","author":"Shin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.06.007_b0200","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-06-0646","article-title":"Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs","volume":"12","author":"Ono","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.06.007_b0205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.canlet.2011.06.007_b0210","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1021\/jf100601r","article-title":"Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice","volume":"58","author":"Kuo","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.canlet.2011.06.007_b0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4196\/kjpp.2010.14.6.353","article-title":"Magnolol inhibits LPS-induced NF-\u03baB\/Rel activation by blocking p38 kinase in murine macrophages","volume":"14","author":"Li","year":"2010","journal-title":"Korean J. Physiol. Pharmacol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511003430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511003430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T01:15:11Z","timestamp":1560388511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511003430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0304383511003430"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.06.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}